Terms: = Astrocytoma AND TP53, TRP53, 7157, ENSG00000141510, P04637, LFS1, P53 AND Prognosis
426 results:
1. [Clinicopathological and molecular characteristics of pediatric gliomas: analysis of 111 cases].
Xu H; Niu HL; Wang FH; Xu XK; Wang W; Yuan L; Chen K; Gao Q; Li LP; Xia JQ; Guo ZM
Zhonghua Bing Li Xue Za Zhi; 2024 Sep; 53(9):922-928. PubMed ID: 39231745
[No Abstract] [Full Text] [Related]
2. Comparative genomic landscape of lower-grade glioma and glioblastoma.
Sun X; Jia Q; Li K; Tian C; Yi L; Yan L; Zheng J; Jia X; Gu M
PLoS One; 2024; 19(8):e0309536. PubMed ID: 39208202
[TBL] [Abstract] [Full Text] [Related]
3. Glioma lateralization: Focus on the anatomical localization and the distribution of molecular alterations (Review).
Cini NT; Pennisi M; Genc S; Spandidos DA; Falzone L; Mitsias PD; Tsatsakis A; Taghizadehghalehjoughi A
Oncol Rep; 2024 Oct; 52(4):. PubMed ID: 39155859
[TBL] [Abstract] [Full Text] [Related]
4. Genomics and proteomics to determine novel molecular subtypes and predict the response to immunotherapy and the effect of bevacizumab in glioblastoma.
Luo D; Luo A; Hu S; Ye G; Li D; Zhao H; Peng B
Sci Rep; 2024 Jul; 14(1):17630. PubMed ID: 39085480
[TBL] [Abstract] [Full Text] [Related]
5. A syngeneic spontaneous zebrafish model of
Weiss A; D'Amata C; Pearson BJ; Hayes MN
Elife; 2024 Jul; 13():. PubMed ID: 39052000
[TBL] [Abstract] [Full Text] [Related]
6. A case series of osseous metastases in patients with glioblastoma.
Webb LM; Webb MJ; Campian JL; Caron SJ; Ruff MW; Uhm JH; Sener U
Medicine (Baltimore); 2024 Jul; 103(27):e38794. PubMed ID: 38968484
[TBL] [Abstract] [Full Text] [Related]
7. NEK2 promotes tp53 ubiquitination to enhance the proliferation and migration of tp53 wild-type glioblastoma cells.
Zhang Y; Yu H; He M; Liu W; Xiao S; Wang X; Huang P; Huang Q
Neoplasma; 2024 Jun; 71(3):255-265. PubMed ID: 38764296
[TBL] [Abstract] [Full Text] [Related]
8. Genomic landscape of glioblastoma without IDH somatic mutation in 42 cases: a comprehensive analysis using RNA sequencing data.
Okamoto T; Mizuta R; Takahashi Y; Otani Y; Sasaki E; Horio Y; Kuroda H; Matsushita H; Date I; Hashimoto N; Masago K
J Neurooncol; 2024 May; 167(3):489-499. PubMed ID: 38653957
[TBL] [Abstract] [Full Text] [Related]
9. Molecular characterization and survival analysis of a cohort of glioblastoma, IDH-wildtype.
Dundar B; Alsawas M; Masaadeh A; Conway K; Snow AN; Sompallae RR; Bossler AD; Ma D; Lopes Abath Neto O
Pathol Res Pract; 2024 May; 257():155272. PubMed ID: 38631135
[TBL] [Abstract] [Full Text] [Related]
10. DKK3 Expression in Glioblastoma: Correlations with Biomolecular Markers.
Caffo M; Casili G; Caruso G; Barresi V; Campolo M; Paterniti I; Minutoli L; Ius T; Esposito E
Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612910
[TBL] [Abstract] [Full Text] [Related]
11. p53/E2F7 axis promotes temozolomide chemoresistance in glioblastoma multiforme.
Meng J; Qian W; Yang Z; Gong L; Xu D; Huang H; Jiang X; Pu Z; Yin Y; Zou J
BMC Cancer; 2024 Mar; 24(1):317. PubMed ID: 38454344
[TBL] [Abstract] [Full Text] [Related]
12. Clinicopathological and molecular landscape of 5-year IDH-wild-type glioblastoma survivors: A multicentric retrospective study.
Miele E; Anghileri E; Calatozzolo C; Lazzarini E; Patrizi S; Ciolfi A; Pedace L; Patanè M; Abballe L; Paterra R; Maddaloni L; Barresi S; Mastronuzzi A; Petruzzi A; Tramacere I; Farinotti M; Gurrieri L; Pirola E; Scarpelli M; Lombardi G; Villani V; Simonelli M; Merli R; Salmaggi A; Tartaglia M; Silvani A; DiMeco F; Calistri D; Lamperti E; Locatelli F; Indraccolo S; Pollo B
Cancer Lett; 2024 Apr; 588():216711. PubMed ID: 38423245
[TBL] [Abstract] [Full Text] [Related]
13. Genetic mutation patterns among glioblastoma patients in the Taiwanese population - insights from a single institution retrospective study.
Huang YF; Chiao MT; Hsiao TH; Zhan YX; Chen TY; Lee CH; Liu SY; Liao CH; Cheng WY; Yen CM; Lai CM; Chen JP; Shen CC; Yang MY
Cancer Gene Ther; 2024 Jun; 31(6):894-903. PubMed ID: 38418842
[TBL] [Abstract] [Full Text] [Related]
14. Molecular signature of stem-like glioma cells (SLGCs) from human glioblastoma and gliosarcoma.
Zechel C; Loy M; Wegner C; Dahlke E; Soetje B; Baehr L; Leppert J; Ostermaier JJ; Lueg T; Nielsen J; Elßner J; Willeke V; Marzahl S; Tronnier V; Madany Mamlouk A
PLoS One; 2024; 19(2):e0291368. PubMed ID: 38306361
[TBL] [Abstract] [Full Text] [Related]
15. Rise of oligodendroglioma hypermutator phenotype from a subclone harboring tp53 mutation after TMZ treatment.
Higuchi F; Uzuka T; Matsuda H; Sumi T; Iwata K; Namatame T; Shin M; Akutsu H; Ueki K
Brain Tumor Pathol; 2024 Apr; 41(2):80-84. PubMed ID: 38294664
[TBL] [Abstract] [Full Text] [Related]
16. General Clinico-Pathological Characteristics in Glioblastomas in Correlation with p53 and Ki67.
Sipos TC; Kövecsi A; Ovidiu-Ioan Ș; Zsuzsánna P
Medicina (Kaunas); 2023 Oct; 59(11):. PubMed ID: 38003967
[No Abstract] [Full Text] [Related]
17. Comparative Analysis of IDH Wild-Type Multifocal and Unifocal Glioblastomas: Prognostic Factors and Survival Outcomes in Focus.
Habiboglu R; Kayali I; Saricanbaz I; Tezcan Y
Turk Neurosurg; 2023; 33(6):1126-1131. PubMed ID: 37846543
[TBL] [Abstract] [Full Text] [Related]
18. Novel insight into histological and molecular astrocytoma, IDH-mutant, Grade 4 by the updated WHO classification of central nervous system tumors.
Chen W; Guo S; Wang Y; Shi Y; Guo X; Liu D; Li Y; Wang Y; Xing H; Xia Y; Li J; Wu J; Liang T; Wang H; Liu Q; Jin S; Qu T; Li H; Yang T; Zhang K; Wang Y; Ma W
Cancer Med; 2023 Sep; 12(18):18666-18678. PubMed ID: 37667984
[TBL] [Abstract] [Full Text] [Related]
19. Potential Prognostic Value of GATA4 Depends on the p53 Expression in Primary Glioblastoma Patients.
Trąbska-Kluch B; Braun M; Orzechowska M; Paszek S; Zuchowska A; Sołek J; Kluska A; Fijuth J; Jesionek-Kupnicka D; Zawlik I
Genes (Basel); 2023 May; 14(6):. PubMed ID: 37372326
[TBL] [Abstract] [Full Text] [Related]
20. Practice of IDH1, ATRX, and p53 Immunohistochemistry in Integrated Diagnosis of Adult Diffuse Gliomas: Single Center Study.
Shabanzadeh Nejabad Z; Mabroukzadeh Kavari H; Saffar H; Tavangar SM; Sefidbakht S; Khoshnevisan A; Zare-Mirzaie A; Vasei M; Jafari E; Yaghmaii M; Saffar H
Appl Immunohistochem Mol Morphol; 2023 Jul; 31(6):390-398. PubMed ID: 37278280
[TBL] [Abstract] [Full Text] [Related]
[Next]
